Vivos Therapeutics launches restructuring plan targeting $3.6 million in annual savings starting Q4 2026

Bitget2026/09/29 12:45

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Vivos Therapeutics launched a restructuring plan targeting USD 3.6 million in annual cost savings, starting in Q4 2026.
Measures include staff cuts, vendor changes, renegotiated contracts, with additional reductions effective Oct. 1, 2026.
Management expects the full run-rate impact of the cost cuts to be reflected in the fourth quarter.
Combined with revenue initiatives, the company targets cash-flow positive results by late 2026 or early 2027.
Profitability target remains 2027, supported by ongoing replacement of legacy IT and software systems to reduce labor costs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609290845PRIMZONEFULLFEED9835949) on September 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Vivos Therapeutics launches restructuring plan targeting $3.6 million in annual savings starting Q4 2026

You may also like

Crypto prices